글로벌 골수유래 줄기세포(BMSCS) 시장 – 2029년까지의 산업 동향 및 예측

글로벌 골수유래 줄기세포(BMSCS) 시장 분석 및 규모

골수 생검은 서구 경제권 외에도 점점 더 많은 관심을 받고 있습니다. 전 세계 개발도상국에서 첨단 의료 기술을 도입하는 것이 시장 성장의 길을 개척하고 있습니다. 수확의 용이성과 다중선형 분화 잠재력 덕분에 골수 유래 줄기 세포(BMSCS) 시장은 밝은 미래를 가지고 있습니다.

• Data Bridge Market Research는 골수 유래 줄기 세포(BMSCS) 시장이 예측 기간 동안 10.90%의 CAGR을 경험할 것으로 분석했습니다. 이는 2021년에 74억 5천만 달러였던 시장 가치가 2029년에는 170억 4천만 달러로 급증할 것임을 나타냅니다. 신생아의 혈액 세포를 미래에 사용하기 위해 보존하는 관행에 대한 인식이 높아짐에 따라 "샘플 보존 및 보관"이 골수 유래 줄기 세포(BMSCS) 시장의 서비스 유형 세그먼트를 지배하고 있습니다.

글로벌 골수유래 줄기세포(BMSCS) 시장 정의

골수 유래 줄기 세포(BMSCS)는 다계통 분화 잠재력을 가진 다능성 성인 줄기 세포입니다. 골수 유래 줄기 세포(BMSCS)는 내인성 복구 과정을 자극하는 인자를 분비하여 부러지거나 손상된 뼈를 복구하는 데 도움이 됩니다.            

보고 범위 및 시장 세분화

Bone Marrow-Derived Stem Cells (BMSCS) Market Dynamics

Drivers

• Rising prevalence of diseases

Growing prevalence of problems accompanies with the bone marrow diseases all around the globe is one of the major factors responsible for the growth of the market. In other words, rising incidence rate of leukaemia, aplastic anaemia, myeloproliferative disorders, and others is inducing growth of the market.

• Research and development proficiencies

Rising expenditure for research and development proficiencies especially in the developed and developing economies will further create lucrative market growth opportunities. Research and development proficiencies being conducted for sample analysis and transportation is also bolstering the market growth rate.

• Growing development of healthcare infrastructure  

Surging number of public private partnerships for the development of healthcare facilities and infrastructure especially in the developing economies is fostering the growth of the market. Rising introduction of novel technologies for the preservation of stem cells and their storage as a collaborative effort of public and private players is further bolstering the growth of the market.     

Opportunities

Furthermore, upsurge in the public-private funding for target research activities, rising awareness about the benefits of , growing awareness on the therapeutic potential of stem cells, rising development of novel technologies for stem cell preservation, processing and storage, rising geriatric population base and rising product innovations and development owing to technological advancements all around the world will extend profitable opportunities for the market players in the forecast period of 2022 to 2029. Additionally, rise in the birth rate, high operational costs associated with stem cell banking and increasing per capita expenditure on health care will further expand the market's growth rate in the future.    

Restraints/Challenges  Global Bone Marrow-Derived Stem Cells (BMSCS) Market

On the other hand, high cost associated with the research and development proficiencies, limited infrastructural facilities, uneven distribution of medical services and dearth of awareness in the backward economies are expected to obstruct market growth. Also, lack of favorable reimbursement scenario and technology penetration in the developing economies, high operational costs associated with stem cell banking, stringent regulatory framework, limited insurance coverage and regulatory compliance, and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2022-2029.

This bone marrow-derived stem cells (BMSCS) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the bone marrow-derived stem cells (BMSCS) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Bone Marrow-Derived Stem Cells (BMSCS) Market

COVID-19 had a negative impact on the market. This is because of the significant disruptions experienced by their respective manufacturing companies in the pandemic era. Also, disruptions in the supply-chain operations as a result of various precautionary lockdowns further restricted the growth in this phase. Further the aim of individuals to reduce the non-essential expenses in this pandemic phase narrowed down the scope of growth. Also, restrictions imposed on the movement further created hindrances. However, the future of the market is in good shape.

Global Bone Marrow-Derived Stem Cells (BMSCS) Market Scope

The bone marrow-derived stem cells (BMSCS) market is segmented on the basis of service type and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Service type

• Sample Preservation and Storage
• Sample Analysis
• Sample Processing
• Sample Collection
• Transportation

Based on service type, bone marrow-derived stem cells (BMSCS) market is segmented into sample preservation and storage, sample analysis, sample processing, sample collection and transportation.

Application

• Personalized Banking Applications
• Research Applications
• Clinical Applications

Bone marrow-derived stem cells (BMSCS) market has also been segmented based on the application into personalized banking applications, research applications and clinical applications. Research applications have been further segmented into disease treatment studies, life science research and drug discovery. Clinical applications have been further segmented into hematopoietic disorders, autoimmune disorders and other diseases.

Bone Marrow-Derived Stem Cells (BMSCS) Market Regional Analysis/Insights

The bone marrow-derived stem cells (BMSCS) market is analysed and market size insights and trends are provided by country, service type and application as referenced above.

The major countries operating in the bone marrow-derived stem cells (BMSCS) market are U.S., Canada, Mexico in North America, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Brazil, Argentina, Rest of South America as a part of South America, UAE, Saudi Arabia, Oman, Qatar, Kuwait, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America dominates the market because of the strong base of healthcare facilities, increasing stem cell procedure along with preferences of private stem cell banking over public and surging network of stem cell banking services and rising number of research activities in this region.  

Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increase in government initiatives to promote awareness, rise in medical tourism, growing research activities in the region, availability of massive untapped markets, large population pool, and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Bone Marrow-Derived Stem Cells (BMSCS) Market Share Analysis

골수 유래 줄기세포(BMSCS) 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 포함됩니다. 위에 제공된 데이터 포인트는 골수 유래 줄기세포(BMSCS) 시장과 관련된 회사의 초점에만 관련이 있습니다.

골수유래 줄기세포(BMSCS) 시장에서 활동하는 주요 업체는 다음과 같습니다.

• Cord Blood Registry Systems (미국)
• 코드라이프 그룹 리미티드(싱가포르)
• Cryo-Cell International (미국)
• 비아코드(미국)
• Cryo-Save AG(네덜란드)
• LifeCell International(인도)
• 스템사이트(미국)
• 글로벌코드블러드(중국)
• 스마트셀스 인터내셔널(영국)
• Vita34 AG(독일)
• 애벗(미국)
• BD(미국)
• 다카라바이오 주식회사(일본)
• CryoHoldco(멕시코)    

연구 방법론: 글로벌 골수유래 줄기세포(BMSCS) 시장

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석 및 추정됩니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭 다운하세요.

DBMR 연구팀이 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석, 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 이 외에도 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 회사 시장 점유율 분석, 측정 표준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 남겨 업계 전문가에게 문의하세요  https://www.databridgemarketresearch.com/ko/speak-to-analyst/?dbmr=global-bone-marrow-derived-stem-cells-bmscs-market

SKU-52534